CELC Celcuity Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CELC

Price (delayed)

$17.67

Market cap

$538.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.69

Enterprise value

$544.89M

Celcuity is a clinical stage biotechnology company translating discoveries of new cancer sub-types into pioneering companion diagnostics and expanded therapeutic options for cancer patients. Celcuity's 3rd generation diagnostic platform, CELsignia, ...

Highlights
The equity has soared by 50% from the previous quarter and by 4.5% YoY
The quick ratio has declined by 48% year-on-year but it has grown by 21% since the previous quarter
CELC's net income has plunged by 58% YoY and by 13% from the previous quarter
The debt has grown by 6% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://celcuity.com
Peers: OMER OMGA

Key stats

What are the main financial stats of CELC
Market
Shares outstanding
30.45M
Market cap
$538.11M
Enterprise value
$544.89M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.06
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$58.45M
EBITDA
-$58.31M
Free cash flow
-$53.91M
Per share
EPS
-$2.69
Free cash flow per share
-$2.28
Book value per share
$5.77
Revenue per share
$0
TBVPS
$8.08
Balance sheet
Total assets
$191.22M
Total liabilities
$51.45M
Debt
$37.45M
Equity
$139.77M
Working capital
$176.4M
Liquidity
Debt to equity
0.27
Current ratio
13.43
Quick ratio
12.73
Net debt/EBITDA
-0.12
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-39.1%
Return on equity
-54.7%
Return on invested capital
-36.7%
Return on capital employed
-33%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CELC stock price

How has the Celcuity stock price performed over time
Intraday
0.06%
1 week
10.99%
1 month
-11.65%
1 year
82.82%
YTD
21.28%
QTD
-18.19%

Financial performance

How have Celcuity's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$66.23M
Net income
-$63.78M
Gross margin
N/A
Net margin
N/A
The operating income has dropped by 68% year-on-year and by 14% since the previous quarter
CELC's net income has plunged by 58% YoY and by 13% from the previous quarter

Growth

What is Celcuity's growth rate over time

Valuation

What is Celcuity stock price valuation
P/E
N/A
P/B
3.06
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The equity has soared by 50% from the previous quarter and by 4.5% YoY
CELC's price to book (P/B) is 39% more than its last 4 quarters average of 2.2 but 33% less than its 5-year quarterly average of 4.6

Efficiency

How efficient is Celcuity business performance
Celcuity's return on invested capital has increased by 46% YoY but it has decreased by 12% QoQ
The ROE has decreased by 11% from the previous quarter
The return on assets has declined by 10% since the previous quarter but it has increased by 4.9% year-on-year

Dividends

What is CELC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CELC.

Financial health

How did Celcuity financials performed over time
The quick ratio has declined by 48% year-on-year but it has grown by 21% since the previous quarter
Celcuity's current ratio has decreased by 47% YoY but it has increased by 20% from the previous quarter
The debt is 73% less than the equity
The equity has soared by 50% from the previous quarter and by 4.5% YoY
The company's debt to equity fell by 33% QoQ but it rose by 3.8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.